日本非传染性紫外炎患者的现实治疗模式:使用大规模索赔数据库进行描述性研究 (J-CAT研究)
Sentaro Kusuhara1, Koh-Hei Sonoda2, Toshikatsu Kaburaki3
1Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. kusu@med.kobe-u.ac.jp.
Journal of ophthalmic inflammation and infection
|July 22, 2025
概括
在日本,皮质类固醇对于非传染性脑膜炎 (NIU) 是常见的,但对于中度至重度的病例,经常使用其他治疗方法. 早期治疗至关重要,因为眼部并发症,如玻璃眼病,在第一年更为常见.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非传染性脑膜炎 (NIU) 是一组可能导致视力丧失的炎症性眼病.
- 对NIU的治疗策略因严重程度而异,轻度病例通常用局部皮质类固醇治疗,而中度至重度病例可能需要全身治疗.
研究的目的:
- 调查日本非传染性脑膜炎 (NIU) 的现实世界治疗模式.
- 分析用于NIU管理的各种疗法的利用,包括皮质类固醇,免疫抑制剂和生物药物.
主要方法:
- 对日本大型保险索赔数据库的分析 (2016年10月至2023年10月).
- 使用ICD-10代码识别NIU患者,并通过眼科检查确认.
- 利用桑基图来可视化治疗过渡和评估眼部并发症和手术.
主要成果:
- 皮质类固醇眼滴是轻度NIU的主要治疗方法 (68.7%).
- 口服皮质类固醇 (19.0%) 和子的注射是中度至重的NIU常见的.
- 在治疗的第一年,观察到眼部并发症的发生率更高,包括青光眼.
结论:
- 皮质类固醇仍然是日本NIU治疗的基石.
- 在中度至重度的NIU中,与局部皮质类固醇一起或作为其替代品使用多种治疗方式.
- 这些发现突显了复杂的治疗环境和NIU管理中的潜在未满足需求.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23
Open Angle Glaucoma: Treatment
577
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
577
Angle Closure Glaucoma: Treatment
691
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
691
Rheumatic Heart Disease III: Medical Management
33
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
33
Nephrotic Syndrome III : Nursing Management
46
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
46
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203


